Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Reckitt, Abbott and Mead Johnson
Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case
The Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.
Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win
Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas
A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not liable after a boy consumed the companies’ cow’s milk-based products for premature infants and became severely ill.
Abbott, Reckitt cleared of liability in latest preterm formula case
By Brendan Pierson (Reuters) -Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature baby formulas' risks.
Abbott, Reckitt Score First Victory in Baby Formula Trial
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy.
Abbott jumps as jury says company, Reckitt not liable in infant formula case
Financial writer covers Abbot's 4.3% rise after being found not liable in baby formula lawsuit, along with Reckitt Benckiser.
Abbott shares rise after securing first win in premature infant formula trial
Abbott Laboratories shares rose nearly 5% before the bell on Friday, after a jury cleared the company and a Reckitt unit of liability in a lawsuit over their premature baby formulas' risks.A jury in St.
4d
Abbott, Mead Johnson Win Defense Verdict Over Preemie Infant Formula
In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
4d
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
The ruling by a Missouri state court jury is a rare legal win for Abbott Laboratories, maker of Similac formula, and Reckitt, ...
4d
Abbott, Mead Johnson secure win in infant formula trial, Reuters reports
Abbott (ABT) and Reckitt Benckiser’s (RBGLY) unit Mead Johnson are not responsible for a young boy’s debilitating intestinal ...
Dairy Reporter
4d
Mead Johnson, Abbott Laboratories cleared in NEC trial
The infant formula manufacturers were facing $6.2bn in punitive damages over allegations their infant formula products caused ...
6d
Kirkland Lawyer Sanctioned in Infant Formula Case
The sanction banned the attorney from presenting evidence or closing arguments for the remainder of the trial.
1d
Abbott Laboratories’ Legal Victory Strengthens Future Outlook and Supports Buy Rating
Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Abbott
Reckitt
Feedback